Avalanche Biotechnologies (AAVL) and Annapurna Therapeutics Announce Merger – StreetInsider.com

Avalanche Biotechnologies, Inc. (Nasdaq: AAVL) and Annapurna Therapeutics SAS, a privately held biopharmaceutical company, today announced that they have entered into a definitive agreement providing for the acquisition of all outstanding shares of Annapurna by Avalanche in exchange for approximately 17.6 million newly issued shares of Avalanche common stock.

Read more at: https://www.streetinsider.com/Corporate+News/Avalanche+Biotechnologies+(AAVL)+and+Annapurna+Therapeutics+Announce+Merger/11263920.html

Font Resize